Skip to main content
. 2017 Sep 22;61(10):e00875-17. doi: 10.1128/AAC.00875-17

TABLE 2.

Comparison of susceptibility rates for ceftazidime-avibactam (CZA) and ceftolozane-tazobactam (C/T) among meropenem-nonsusceptible P. aeruginosa isolates stratified by the presence of nonsusceptibility to other β-lactam agents

β-Lactam agent(s)a to which isolates were NS (no. of isolates/total, %) S to CZA (no. of isolates, %) S to C/T (no. of isolates, %) P valueb
FEP (168/290, 58) 114, 68 142, 85 0.0003
CAZ (157/290, 54) 105, 67 132, 84 0.0006
TZP (185/290, 64) 133, 72 159, 86 0.0013
ATM (183/290, 63) 132, 72 159, 87 0.0007
FEP and CAZ (133/290, 46) 82, 62 108, 81 0.0006
FEP and TZP (147/290, 51) 97, 66 122, 83 0.0012
FEP and ATM (131/290, 45) 82, 63 108, 82 0.0005
CAZ and TZP (145/290, 50) 95, 66 121, 83 0.0007
CAZ and ATM (121/290, 42) 73, 60 99, 82 0.0004
TZP and ATM (148/290, 51) 99, 67 125, 85 0.0006
FEP, CAZ, and TZP (127/290, 44) 78/127, 61 103/127, 81 0.0008
FEP, CAZ, and ATM (106/290, 37) 59/106, 56 84/106, 79 0.0004
FEP, TZP, and ATM (121/290, 42) 73/121, 60 98/121, 81 0.0006
CAZ, TZP, and ATM (118/290, 41) 70/118, 59 96/118, 81 0.0003
All 4 β-lactam agents (103/290, 36) 56/103, 54 81/103, 79 0.0004
a

Abbreviations: S, susceptible; NS, nonsusceptible; ATM, aztreonam; FEP, cefepime; CZA, ceftazidime-avibactam; C/T, ceftolozane-tazobactam; CAZ, ceftazidime; TZP, piperacillin-tazobactam.

b

Comparisons were conducted using Fisher's exact test.